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medication reconciliation, and medication access. This study has a pre-post design 
with control sites to provide scientific evidence of the clinical and economic impact 
of the interventions. The data collected includes measures of health outcomes, 
medication-related problems, and pharmacist interventions. Results: 3,001 
unique patients were seen by the pharmacy teams during the initial 13 months. A 
majority of these patients suffer from uncontrolled diabetes, hypertension or both. 
For patients with baseline A1C> 9%, 30% achieved A1C < 8% in the intervention group 
versus 13% in the control group after 180 days. For patients with initial BP > 140/90, 
87% of patients in the intervention group achieved BP < 140/90 within 45 days. 19,696 
medication-related problems were documented for 1,993 patients. Problems were 
categorized into four groups including appropriateness/effectiveness(43%), medica-
tion safety(18%), medication nonadherence/misuse(27%), and miscellaneous(9%). 
2,150 potential adverse drug events (pADEs) were identified and resolved for patients 
seen by the clinical pharmacy teams. The most common pADEs were excessive dos-
ing, adverse drug reactions, and polypharmacy. ConClusions: The integration of 
clinical pharmacy teams into the patient-centered medical home improves health 
outcomes and medication safety.
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EPidEmiology of PSycHiatric HoSPitalizationS Public HEaltH SyStEm 
in brazil bEtwEEn 2010 and 2012
Figueiredo ACDD 
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objeCtives: This study aims to analyze the profile of psychiatric hospitalizations 
within the public health service in Brazil between 2010 and 2012, analyzing the main 
causes of hospitalization, according to the International Classification of Diseases 
(WHO CID.10), the profile of patient and place of residence in Brazil. Methods: Is 
a descriptive study on the profile of psychiatric hospitalizations within the public 
system of Brazil present in the database of the Hospital Information System (HIS) of 
the Ministry of Health from January 2010 to December 2012. Results: Data analysis 
showed that there was no significant change in the number of cases between 2010 
and 2012; the total number has remained at an average of 280.150 admissions per 
year. Remained the same profile of hospitalization: the majority of were for males 
(65%), 40% white, 26% brown and 6% black, and 28% of hospitalized patients do not 
report skin color. The most admissions occurred between the ages of 30 and 49 years 
(50%).Regarding the causes of hospitalization, classified according to ICD-10 (F00-
F99), the pattern found was 35% of the causes of hospitalization for schizophrenia, 
20% are disorders related to alcohol use, 18% are related disorders psychotropic and 
18% are mood disorders. Other causes, such as dementia, and others appear less 
than 5% of cases each. Regarding the profile of admissions by place of residence, it 
was observed that the more developed regions of the country had the highest per-
centage of hospitalizations, Southeast (42%) and South (28%). ConClusions: This 
study show that use of secondary data in surveys, from information system health, 
plus the low cost generated, an important source of epidemiological information, 
especially in countries with universal coverage of public health services such as 
Brazil , in which the majority of the population depends on the public health system.
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PnEumococcal VaccinE targEting StratEgy for tHE oldEr adultS: 
cuStomizEd riSk Profiling
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objeCtives: Current pneumococcal vaccine campaigns take a broad, primarily age-
based approach to immunization targeting, overlooking many clinical and admin-
istrative considerations necessary in disease prevention and resource planning for 
specific patient populations. We aim to demonstrate the utility of a population-
specific predictive model for hospital-treated pneumonia to direct effective vaccine 
targeting. Methods: Data was extracted for 1,053,435 members of an Israeli HMO, 
age 50 and older, during the study period 2008-2010. We developed and validated 
a logistic regression model to predict hospital-treated pneumonia using training 
and test samples, including a set of standard and population-specific risk factors. 
The model’s predictive value was tested for prospectively identifying cases of pneu-
monia and invasive pneumococcal disease (IPD), and was compared to the existing 
international paradigm for patient immunization targeting. Results: In a multi-
variate regression, age, co-morbidity burden and previous pneumonia events were 
most strongly positively associated with hospital-treated pneumonia. The model 
predicting hospital-treated pneumonia yielded a c-statistic of 0.80. Utilizing the 
predictive model, the top 17% highest-risk within the study validation population 
were targeted to detect 54% of those members who were subsequently treated for 
hospitalized pneumonia in the follow up period. The high-risk population identi-
fied through this model included 46% of the follow-up year’s IPD cases, and 27% of 
community-treated pneumonia cases. These outcomes were compared with inter-
national guidelines for risk for pneumococcal diseases that accurately identified 
only 35% of hospitalized pneumonia, 41% of IPD cases and 21% of community-
treated pneumonia. ConClusions: We demonstrate that a customized model for 
vaccine targeting performs better than international guidelines, and therefore, risk 
modeling may allow for more precise vaccine targeting and resource allocation than 
current national and international guidelines. Health care managers and policy-
makers may consider the strategic potential of utilizing clinical and administra-
tive databases for creating population-specific risk prediction models to inform 
vaccination campaigns.
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events (N= 9 of 12, 75 %). This may contribute to improved health care utilization, as 
measured by the lower rates of hospitalization or emergency department visits (N= 7, 
78%). PMAS also resulted in cost-savings in seven of the studies. ConClusions: 
Pharmacist-lead outpatient anticoagulation services attained better quality of anti-
coagulation control, lower bleeding and thromboembolic events, and lower health 
care utilization.
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tHE imPact of HomE mEdication rEViEw in PatiEntS witH tyPE 2 
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objeCtives: To investigate whether Home Medication Review (HMR) conducted 
by a pharmacist can improve the clinical indices, quality of life and medication 
adherence in patients with Type 2 Diabetes Mellitus (T2DM). Methods: Six month 
prospective, randomized, controlled study. Adult T2DM patients taking medications 
for diabetes for at least two years, with HbA1c> 8%, were recruited into the study 
and randomized to intervention or control. The intervention group received three 
home visits by a pharmacist (at baseline, 3 months and at 6 months), and one group 
counselling session with a dietician in addition to the standard medical care. Control 
group patients only received standard medical care. Primary outcome measures 
were HbA1c and fasting blood sugar (FBS). Secondary outcome measures include 
lipid profile (triglycerides, LDL- and HDL-cholesterol); blood pressure (BP); medi-
cation adherence (assessed using modified Morisky adherence scale); and qual-
ity of life (QoL) assessed using the Short form health survey (SF-36v2). Outcomes 
were evaluated at baseline, 3 months and at 6 months. Results: 73 patients were 
recruited and randomized to the intervention group (38) or the control group (35), 
with no significant difference identified in baseline parameters. Data was analysed 
in SPSSv19(IBM) using ANOVA and paired t-test. There were significant improve-
ments from baseline to 6 months in the intervention group in; HbA1c (mean dif-
ference (MD) = 1.57, 95% CI[0.88, 2.26], p< 0.001); FBS (MD= 2.76, 95% CI[0.59,4.94], 
p= 0.009); systolicBP (MD= 6.56, 95% CI[0.75,12.36], p= 0.022); diastolicBP (MD= 4.44, 
95% CI[1.11,7.78], p= 0.006); triglycerides (MD= 0.59, 95% CI[0.24,0.93], p< 0.001) and 
medication adherence (MD= -2.19, 95% CI[-2.73,-1.65], p< 0.001). The control group 
showed no significant changes in outcome measures. QoL improved in the interven-
tion group but declined in controls. ConClusions: In this study, HMR conducted by 
a pharmacist provided significant improvement in health and QoL of patients with 
Type 2 Diabetes Mellitus. HMR may be beneficial for patients with chronic diseases 
and for the health care system.
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incraSEd-doSE HEPatitiS b ViruS VaccinE imProVE tHE immunE 
rESPonSE in HiV-infEctEd PatiEntS: a mEta-analySiS
Zhao X, Lin P, Wu WK
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objeCtives: Hepatitis B co-infection may lead to increased mortality of HIV 
patients. All HIV-infected patients are recommended to receive hepatitis B virus 
(HBV) vaccination to prevent the co-infection. However, HIV-infected patients often 
fail to produce protective antibodies to HBV vaccine. This study is sought to assess 
the efficacy of increased-dose HBV vaccine in HIV-infected patients. Methods: A 
systematic literature review and meta-analysis of clinical trials were conducted. 
The search was carried out on PubMed, EMBASE and the Cochran Database of 
Systematic Reviews, from beginning of databases to December 2013. Keywords 
used in the electronic searches included “hepatitis b”, “HBV”, “vaccine”, “vaccina-
tion”, “immunization”, “HIV”, and “ADIS”. We only included studies those published 
in full-text papers. Inclusion criteria are as follows: English language and rand-
omized control trials those compare the response rates of increased-dose HBV 
vaccine (increase dose or administration times of standard dose) and standard-
dose vaccine (20μ g 3 times at month 0, 1, and 6) in HIV-infected patients. Random 
effect model with heterogeneity analyses were used. The result was reported by 
risk ratio. Statistical analyses were performed using the software program Review 
Manager 5.2. Results: Of 1204 references yielded by electronic searches, five 
trials, which represent a total of 424 patients, were included in the final analysis. 
The heterogeneity was moderate (I2= 32%) according to the I42 test. Pooling of 
study results showed a significant increase in response rate among increased-
dose patients versus control patients; the pooled risk ratio (RR) was 1.17 (95% CI: 
1.06-1.30). The number of intent-to-treat is 9. Only one study presented severe 
adverse reaction reports related to the vaccination, and no increased risk was 
observed. ConClusions: Increasing the dosage of vaccine may improve the 
immune responses significantly in HIV-infected patients.
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intEgration of clinical PHarmacy SErVicES
O’Callaghan R1, Joyce G1, Chen S2
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objeCtives: Medications must be prescribed and administered properly to be effec-
tive for the treatment of chronic conditions. Medication errors and poor adherence 
lead to increased costs and poor outcomes. Evidence shows that clinical outcomes 
improve when pharmacists are integrated into the care team. The objectives of this 
study were to improve health care quality, medication safety, and reduce health 
care costs for high-risk patients through the integration of clinical pharmacy ser-
vices into patient-centered medical homes. Methods: Clinical pharmacy teams 
consisting of a pharmacist, resident, and pharmacy technician were integrated into 
five safety net clinics starting in September 2012. Five additional sites were added 
in October 2013. These teams target high-risk patients with poor chronic disease 
control. The services provided include medication and disease state management, 
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objeCtives: Cholera, a key social development indicator remains an acute global 
public health threat (Dunkle ,2011 Penguele, 2011). Ghana has seen recurrent 
epidemics in recent years, posing health system challenge. This study aimed to 
describe, identify the cause and socio-economic factors associated with 2012 chol-
era outbreak in Osu-Klottey district for policy recommendations. Methods: We 
conducted descriptive and unmatched case-control study. Cholera case-patient was 
person with acute diarrhea with/without vomiting in the district from 1st March to 
30th November 2012. We interviewed participants on socio-economic, household 
hygiene, food, water exposures with structured questionnaires and mapped their 
residence geospatially. Data was managed and analyzed in Stata 11/SE. Results: 
Index case, 23 year old male Nima resident reported at Ridge hospital on 9th March 
2012 after eating street-vendors “Waakye”. The outbreak caused by Vibrio cholerae 
O1 El-Tor biotype, serotype ogawa had two peaks with total of 494 cases with 3 
mortalities (Attack rate; 383/100,000 populations, 0.61% fatality). Age ranged 2- 83; 
mean and median 31+/-14.4 and 27 years respectively. Majority of cases were from 
Ayawaso and Osu-Klottey. Prompt case management, infection prevention prac-
tices, contact tracing, sensitization campaigns and proper cadaver disposal were 
instituted. Monthly income, daily-food-expenditure ranged 10–500 USD and 0.50–25 
USD respectively among participants. Logistic regression analysis (95% confidence 
interval) showed age below 18 years (AOR= 7.69, CI 1.38-42.73), education below ter-
tiary (AOR= 2.96, CI 1.16-7.54), exclusive household toilet facility (AOR= 0.289, CI 0.12-
0.70), cold/warm food (AOR= 3.11, CI 1.34-7.23), home food (AOR= 0.083, CI 0.39-0.18) 
and community pipe-borne water (AOR= 2.15, CI 1.04-4.44) were associated. Hand 
washing with soap-water, slum residence, and daily-food-expenditure below 5.0USD 
and alcohol ingestion showed significant association only with bivariate analy-
sis. ConClusions: Sanitary reforms and infrastructural development is crucial to 
combat recurrence of cholera epidemic, however multi-sectorial approach including 
oral cholera vaccine for the under-18 year olds would make significant impact.
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aSSESSmEnt of diabEtES riSk for dEtEction of tyPE 2 diabEtES 
mEllituS in young adultS
Ashok P
Bharati vidyapeeth Medical College, Pune 43, India
objeCtives: According to World Health Organisation , a disease of the middle-aged 
and elderly, type 2 diabetes has recently escalated in all age groups and is now being 
identified in younger and younger age groups, including adolescents and children, 
especially in high-risk population. This underscores the need for mass awareness 
and screening programmes to detect diabetes at an early stage and early age.So 
the purpose of the study is to find risk of type 2 diabetes mellitus mellitus in young 
adults at an early age. Methods: 405 students of Bharati Vidyapeeth Deemed 
University Medical College were screened for family history of diabetes, exercise 
status and waist circumference. After scoring them they were categorised into mild, 
moderate and high risk group. Results: We have assessed 405 students which 
includes 258 girls and 147 boys students till now. It was observed that 4% ,71% & 25 
% students in high, Moderate & Low risk group respectively for developing type 2 
D.M. Mean abdominal obesity in high risk students was 101.95± 5.76 as compared to 
79.17 ± 11.08 in moderate and low risk students(p< 0.0001). Family history of diabetes 
in either or both parents was present in 21% students. 55% students were having 
sedentary lifestyle. ConClusions: This underscores the urgent need for further 
investigations to detect diabetes at an early stage and to overcome the disease 
burden of diabetes in future. This is the simplest way to screen large population. 
Also in students who are having score more than 50. To prevent and to postpone 
the risk of type 2 diabetes mellitus, health education programme, exercise and diet 
planning should be recommended for these students
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tHE dEtErminantS of PlacE of dEatH in an End-of-lifE or PalliatiVE 
carE PoPulation
Costa V1, Holubowich C1, Kaulback K1, Pham B2, Sikich N1
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objeCtives: As part of a series of systematic reviews of end-of-life care interven-
tions we sought to evaluate the determinants of place of death in an end-of-life 
population. Methods: A systematic review of the literature was undertaken in 
order to identify randomized controlled trials, observational studies, or prior sys-
tematic reviews published between January 1, 2004, and September 24, 2013 evalu-
ating the determinants of death in different locations (home, nursing home, and 
inpatient hospice). Determinants related to the illness, living arrangements, support 
to caregiver, hospital bed availability, home or palliative care, patient and fam-
ily preference were evaluated. The adjusted odds ratios (ORs) and 95% confidence 
intervals (CIs) from multivariate analyses were extracted. Meta-analyses were per-
formed when appropriate. Results: Four systematic reviews and 32 observational 
studies were included, mostly retrospective cohort studies based on administra-
tive databases. Three studies (9.4%) were from Canada, 6 (18.8%) from the United 
States, and 9 (28.1%) from Europe. Eight (25%) studies included patients receiving 
multidisciplinary home care, 11 (34.4%) were restricted to cancer patients. Factors 
increasing the likelihood of home vs. hospital death included multidisciplinary 
home care team (OR: 8.40 [95% CI: 4.67–15.09], 1 study), and home visits by family 
physicians in patients receiving home care (OR: 2.26 [1.35–3.78], 3 studies, I2= 22%). 
Admission to a hospital having a multidisciplinary palliative support team or hos-
pice unit decreased the likelihood of home death (OR: 0.54 [0.33–0.89], 2 studies, 
objeCtives: Uganda has a high population growth rate (3.2%) and a high fertil-
ity rate (6.2 children per woman), primarily due to the low prevalence of mod-
ern contraceptive use. We examined factors associated with contraceptive use 
and the choice of contraceptive methods by Ugandan women of reproductive 
age. Methods: We obtained demographic, socioeconomic and contraceptive use 
data on women aged 15-49 years from the Uganda Demographic Health Survey 
(UDHS) 2011. We performed descriptive analyses to examine the frequency of use 
and contraceptive choice. We fit exploratory binary and multinomial logit models 
to examine demographic and socioeconomic factors associated with contraceptive 
use and choice of contraceptive. Results: Our analysis included 8647 women 
with data on contraceptive use. 22.87% reported current use of contraceptives. The 
most commonly used methods were injections (44.25%) and condoms (14.72%). 
In the logit model, higher odds of contraceptive use was associated with higher 
age (OR 1.38 95% CI: 1.29, 1.49), being in a higher wealth quintile (OR 1.27, 95% CI: 
1.21, 1.34), higher level of education (OR 1.28, 95% CI: 1.20, 1.37) and employment 
(OR 1.46, 95% CI: 1.28, 1.65). Women who desired more than 8 children had lower 
odds (OR 0.58, 95% CI: 0.46, 0.73) of using contraceptives. The reference outcome 
group in the multinomial logit model was “not using any contraception”. Age, employ-
ment status, level of education, wealth quintile, region of country, number of 
children and desire for more children as important determinants of choice of 
contraceptive. However the effects differed according to the choice of contracep-
tive. ConClusions: Our study shows that the prevalence of contraceptive use 
is very low in Uganda and identifies some determinants of contraceptive use 
and method choice. There is need to focus reproductive health research towards 
identifying contraceptive characteristics that may influence choice in order to 
design more holistic contraceptive policy.
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longitudinal analySiS of dEnguE fEVEr infEctionS rEPortEd in tHE 
uk bEtwEn 2002 – 2013 uSing tHE HEaltH imProVEmEnt nEtwork (tHin) 
Primary carE databaSE
Ansell D, O’Leary C, Nasser A
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objeCtives: In the UK, dengue fever is a travel associated viral infection which 
is endemic in over 110 countries and is transmitted through a mosquito vector. 
Infection may develop into severe dengue which can lead to death. There is currently 
no licensed immunisation to protect against infection, although vaccines are in 
development. In 2009 the Health Protection Agency in England commenced monitor-
ing the prevalence, so there is no longitudinal data on UK rates. This study describes 
the rates of infections by year and the population characteristics of those acquiring 
dengue fever recorded in a primary care database. Methods: The THIN primary 
care database contains 12 million patients with 3.8 million active patients in 2012. 
An observational, retrospective study was conducted from 1/1/2002 – 31/12/2012. 
All patients with a coded diagnosis of dengue fever in this period were included. 
The variables were: age, gender, ethnicity, social deprivation score and month of 
diagnosis. Results: The annual rates of dengue fever pmp in THIN from 2002 – 2013 
were 4.0, 3.7, 7.9, 5.3, 3.3, 6.5, 5.0, 1.9, 7.4, 5.8, 5.8 respectively. The 4 years of HPA data 
from 2009 to 2012 were very similar to THIN rates (2.9, 7.1, 3.9, 5.9). 58% of patients 
were males. The percentage by age bands 0 – 19, 20-39, 40 – 59, 60+ were 8%, 48%, 
30%, 14% respectively. ConClusions: Between 2002 – 2013 there was year to year 
variability in dengue infection rates, although the UK travellers have seen no rise in 
rates of dengue fever during this period. The 4 years of HPA reported rates are very 
similar to THIN rates. Infection was reported more frequently in males, and almost 
half of infections occurred in the 20–39 year age group. This may just reflect their 
greater propensity to travel to affected destinations.
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objeCtives: To identify incidence and direct medical cost of patients diagnosed 
with all-cause pneumonia and acute otitis media through EMR database and 
health information database (HID) in Minhang district, Shanghai. Methods: 
Cases were definite by ICD-10 code and identified for a two-year period, from 
Jan 1st of 2011 to Dec 31th of 2012 from EMR database. Relevant medical cost was 
collected from HID, ancillary cost data – such as costs of medical procedures, 
medications, and facility utilization was estimated through survey. These data 
were combined used unique patients identification number. Patients were classi-
fied into age groups and incidence and medical costs data were reported based on 
the age groups. Results: The highest incidence of inpatient all-cause pneumonia 
was 795 episodes per 100,000 person-year in children under 2 years, it decreases 
as population ages but reverse the trend with patients age 50 and above. The 
second high incidence appeared in senior people aged 65 and above (249 per 
100,000 person year). There was similar trend for outpatient all- cause pneumonia 
and Acute Otitis Media. The cost analysis indicated that the medical direct cost 
per case increases and population ages. The highest median cost (95% range) for 
hospitalization all-cause pneumonia was RMB 7,851.6 (1,903.7-47,607.4) Yuan for 
age 65 and older, and the lowest cost per case appeared in children under 2 years. 
Similar trend was also observed for the outpatient all-cause pneumonia costs and 
AOM costs. ConClusions: Outpatient all-cause pneumonia is a major public 
burden in current Chinese treatment pattern of pneumococcal relevant diseases, 
especially in children under 5 and senior people age 65 and above. In adults and 
senior people, the medical direct cost of all-cause pneumonia reaches 7,851 RMB 
per episode which accounts for 9.51% of 2011 Shanghai per person GDP and 22.32% 
of 2011China per person GDP.
